Number of Hospitalizations by 7 days post-treatment
Compare number of hospitalization readmissions for CHF between Intervention (Aquaphersis arm) & Control groups
Number of Hospitalizations by 30 days post-treatment
Compare number of hospitalization readmissions for CHF between Intervention (Aquaphersis arm) & Control groups
Number of Hospitalizations by 60 days post-treatment
Compare number of hospitalization readmissions for CHF between Intervention (Aquaphersis arm) & Control groups
Number of Hospitalizations by 90 days post-treatment
Compare number of hospitalization readmissions for CHF between Intervention (Aquaphersis arm) & Control groups
Weight change by 7 days post-treatment
Compare weight change (pounds) in patients between Intervention & Control groups
Weight change by 30 days post-treatment
Compare weight change (pounds) in patients between Intervention & Control groups
Weight change by 60 days post-treatment
Compare weight change (pounds) in patients between Intervention & Control groups
Weight change by 90 days post-treatment
Compare weight change (pounds) in patients between Intervention & Control groups
Total fluid removal
Compare total fluid removal (ml) in patients between Intervention & Control groups
Blood urea nitrogen at Baseline
Compare Blood urea nitrogen (BUN; mg/dl) (higher than normal range is worse) in patients between Intervention & Control groups
Blood urea nitrogen at 7 days post-treatment
Compare Blood urea nitrogen (BUN; mg/dl) (higher than normal range is worse) in patients between Intervention & Control groups
Blood urea nitrogen at 30 days post-treatment
Compare Blood urea nitrogen (BUN; mg/dl) (higher than normal range is worse)) in patients between Intervention & Control groups
Blood urea nitrogen at 60 days post-treatment
Compare Blood urea nitrogen (BUN; mg/dl) (higher than normal range is worse) in patients between Intervention & Control groups
Blood urea nitrogen at 90 days post-treatment
Compare Blood urea nitrogen (BUN; mg/dl) (higher than normal range is worse) in patients between Intervention & Control groups
Creatinine at Baseline
Compare Creatinine (Cr; mg/dl) (higher than normal range is worse) in patients between Intervention & Control groups
Creatinine at 7 days post-treatment
Compare Creatinine (Cr; mg/dl) (higher than normal range is worse) in patients between Intervention & Control groups
Creatinine at 30 days post-treatment
Compare Creatinine (Cr; mg/dl) (higher than normal range is worse) in patients between Intervention & Control groups
Creatinine at 60 days post-treatment
Compare Creatinine (Cr; mg/dl) (higher than normal range is worse) in patients between Intervention & Control groups
Creatinine at 90 days post-treatment
Compare Creatinine (Cr; mg/dl) (higher than normal range is worse) in patients between Intervention & Control groups
Glomerular filtration rate at Baseline
Compare Glomerular filtration rate (GFR; ml/min/1.73 meters squared) (lower than normal range is worse) in patients between Intervention & Control groups
Glomerular filtration rate at 7 days post-treatment
Compare Glomerular filtration rate (GFR; ml/min/1.73 meters squared) (lower than normal range is worse) in patients between Intervention & Control groups
Glomerular filtration rate at 30 days post-treatment
Compare Glomerular filtration rate (GFR; ml/min/1.73 meters squared) (lower than normal range is worse) in patients between Intervention & Control groups
Glomerular filtration rate at 60 days post-treatment
Compare Glomerular filtration rate (GFR; ml/min/1.73 meters squared) (lower than normal range is worse) in patients between Intervention & Control groups
Glomerular filtration rate at 90 days post-treatment
Compare Glomerular filtration rate (GFR; ml/min/1.73 meters squared) (lower than normal range is worse) in patients between Intervention & Control groups
Brain natriuretic peptide (BNP) test at Baseline
Compare BNP (pg/ml of blood) (higher than normal range is worse) in patients between Intervention & Control groups
Brain natriuretic peptide (BNP) test at 7 days post-treatment
Compare BNP (pg/ml of blood) (higher than normal range is worse) in patients between Intervention & Control groups
Brain natriuretic peptide (BNP) test at 30 days post-treatment
Compare BNP (pg/ml of blood) (higher than normal range is worse) in patients between Intervention & Control groups
Brain natriuretic peptide (BNP) test at 60 days post-treatment
Compare BNP (pg/ml of blood) (higher than normal range is worse) in patients between Intervention & Control groups
Brain natriuretic peptide (BNP) test at 90 days post-treatment
Compare BNP (pg/ml of blood) (higher than normal range is worse) in patients between Intervention & Control groups
6-minute Walk Test at Baseline
Compare 6-minute Walk Test (meters/6 minutes; less distance means more disability) in patients between Intervention & Control groups
6-minute Walk Test at 7 days post-treatment
Compare 6-minute Walk Test (meters/6 minutes; less distance means more disability) in patients between Intervention & Control groups
6-minute Walk Test at 30 days post-treatment
Compare 6-minute Walk Test (meters/6 minutes; less distance means more disability) in patients between Intervention & Control groups
6-minute Walk Test at 60 days post-treatment
Compare 6-minute Walk Test (meters/6 minutes; less distance means more disability) in patients between Intervention & Control groups
6-minute Walk Test at 90 days post-treatment
Compare 6-minute Walk Test (meters/6 minutes; less distance means more disability) in patients between Intervention & Control groups
Minnesota Living with Heart Failure Questionnaire (MLWHFQ)
Compare Minnesota Living with Heart Failure Questionnaire (MLWHFQ) (total score; higher score means more impairment) in patients between Intervention & Control groups
Minnesota Living with Heart Failure Questionnaire (MLWHFQ)
Compare Minnesota Living with Heart Failure Questionnaire (MLWHFQ) (total score; higher score means more impairment) in patients between Intervention & Control groups
Minnesota Living with Heart Failure Questionnaire (MLWHFQ)
Compare Minnesota Living with Heart Failure Questionnaire (MLWHFQ) (total score; higher score means more impairment) in patients between Intervention & Control groups
Minnesota Living with Heart Failure Questionnaire (MLWHFQ)
Compare Minnesota Living with Heart Failure Questionnaire (MLWHFQ) (total score; higher score means more impairment) in patients between Intervention & Control groups
Minnesota Living with Heart Failure Questionnaire (MLWHFQ)
Compare Minnesota Living with Heart Failure Questionnaire (MLWHFQ) (total score; higher score means more impairment) in patients between Intervention & Control groups
SF-36 at Baseline
Compare SF-36 weighted sums (0-100 scale; lower score means more disability) in patients between Intervention & Control groups
SF-36 at 7 days post-treatment
Compare SF-36 weighted sums (0-100 scale; lower score means more disability) in patients between Intervention & Control groups
SF-36 at 30 days post-treatment
Compare SF-36 weighted sums (0-100 scale; lower score means more disability) in patients between Intervention & Control groups
SF-36 at 60 days post-treatment
Compare SF-36 weighted sums (0-100 scale; lower score means more disability) in patients between Intervention & Control groups
SF-36 at 90 days post-treatment
Compare SF-36 weighted sums (0-100 scale; lower score means more disability) in patients between Intervention & Control groups
Adverse events: bleeding incidents during Outpatient treatment
Compare number of Adverse Events (bleeding incidents) in patients between Intervention & Control groups: bleeding, line-related infection, etc.
Adverse events: line infections during Outpatient treatment
Compare number of Adverse Events (line infections) in patients between Intervention & Control groups: bleeding, line-related infection, etc.
Costs
Compare costs (dollars) between Intervention & Control groups